Figure 3: Liraglutide Decreased Aortic Plaque Lesion Development in ApoE

(A) WD-induced increases in body weight were significantly lowered by liraglutide and in the weight matched comparator: ****p < 0.0001 versus vehicle, WD. (B) Liraglutide significantly attenuated WD-induced plaque lesion development, whereas the weight-matched comparator group did not: *p = 0.0448, ****p <0.0001 versus vehicle, WD; liraglutide, WD versus weight-matched, WD, p = 0.06. Abbreviations as in Figure 1.



Elsevier user license